Drugs News and Research

RSS

Antibody drug improves survival rates in canine prostate cancer model

Dogs are proving to be a far better scientific model for study of prostate cancer than mice, the typical animal used in the lab for this type of research.

8 Feb 2022

Study finds rising racial disparities in opioid and stimulant deaths

Between 2009 and 2019, overdose deaths in the United States involving opioids and stimulant drugs, such as cocaine and methamphetamine, surged compared to deaths from stimulants alone.

8 Feb 2022

Study uncovers a series of natural products that can inhibit the main protease of SARS-CoV-2

The fight against the COVID-19 pandemic is an international scientific challenge regarding the search for strategies to fight the viral infection and prevent its damaging consequences.

7 Feb 2022

Investigating taraxerol as a protease inhibitor against SARS-CoV-2

In a recent study posted to the Research Square preprint* server, a team of researchers investigated the toxicity and absorption, distribution, metabolism, and excretion (ADME) characteristics of a potent herbal drug, taraxerol, in the management of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The paper is under consideration for publication in the Structural Chemistry journal.

7 Feb 2022

"Drug checking" programs have unexpected benefits, study finds

A recent study has found that so-called "drug checking" programs have unexpected benefits, allowing public health programs to reach and work with people who use drugs who would otherwise not access services such as HIV testing.

7 Feb 2022

Paracetamol use increases blood pressure, study shows

Long-term paracetamol use could increase the risk of heart disease and strokes in people with high blood pressure, a study suggests.

7 Feb 2022

Study shows a small increased risk of congenital abnormalities in infants exposed to opioids in utero

A new study in CMAJ shows a small increased risk of congenital abnormalities in infants exposed to opioid medications in the first trimester of pregnancy.

7 Feb 2022

Innate immune processes involved in SARS-CoV-2 recognition and resultant inflammation

A new article reviewed the innate immune detection and signaling pathways that the host uses against SARS-CoV-2.

7 Feb 2022

Using interdisciplinary approach to beat cancer

European Cooperation in Science and Technology (COST) World Cancer Day aims at raising awareness of cancer and to encourage its prevention, detection, and treatment.

4 Feb 2022

Older people at highest risk of death are least likely to receive effective COVID-19 treatment

People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)—a highly effective treatment for the disease—both across and within U.S. states, according to new research co-authored by researchers from Harvard T.H. Chan School of Public Health.

4 Feb 2022

Gene therapy helps heart muscle cells electrically activate in live mice

Biomedical engineers at Duke University have demonstrated a gene therapy that helps heart muscle cells electrically activate in live mice.

4 Feb 2022

Scientists elucidate the structure of central cellular inflammatory switch

Researchers at the Universities of Bonn and Regensburg have elucidated the structure of a central cellular inflammatory switch.

4 Feb 2022

Drug used to treat skin and lung cancers slows the progression of ovarian cancer sub-type

A drug currently used to treat skin and lung cancers has been found to slow the progression of a form of ovarian cancer and increase the number of patients who respond to treatment, a clinical trial has found.

4 Feb 2022

New cloud-based data resource helps researchers to identify subtypes of ALS

A new cloud-based data resource co-developed by scientists at Cedars-Sinai provides the research community with a comprehensive set of tools to help identify new subtypes of amyotrophic lateral sclerosis (ALS), a fatal neurological disorder.

4 Feb 2022

Evaluating effects of D614G and P681R/H mutations on SARS-CoV-2 VOCs

Researchers evaluate how the D614G and P681H mutations alter the attributes of SARS-CoV-2 VOCs.

3 Feb 2022

Roswell Park scientists identify a potential new treatment target for pancreatic cancer

Scientists at Roswell Park Comprehensive Cancer Center have identified a potential new target for the treatment of pancreatic cancer.

3 Feb 2022

Scientists identify genome regions linked to migraine risk

An international consortium of leading migraine scientists identified more than 120 regions of the genome that are connected to risk of migraine.

3 Feb 2022

Genome study reveals unexpected heterogeneity of human ribosomal RNA genes

A genome study undertaken by Johns Hopkins Kimmel Cancer Center researchers to look for variants in a gene considered a fundamental building block for microscopic structures that synthesize proteins took a surprising twist.

2 Feb 2022

Study offers unprecedented insight into the mechanism of action of topo VI enzyme

The function of an enzyme, critical to most forms of life, has been revealed.

2 Feb 2022

UK's world-leading human challenge study provides new insights into mild SARS-CoV-2 infections

Findings from the UK's world-leading human challenge study provide new insights into mild infections with SARS-CoV-2 in healthy young adults.

2 Feb 2022

Drugs News and Research

Antibody drug improves survival rates in canine prostate cancer model

Study finds rising racial disparities in opioid and stimulant deaths

Study uncovers a series of natural products that can inhibit the main protease of SARS-CoV-2

Investigating taraxerol as a protease inhibitor against SARS-CoV-2

"Drug checking" programs have unexpected benefits, study finds

Paracetamol use increases blood pressure, study shows

Study shows a small increased risk of congenital abnormalities in infants exposed to opioids in utero

Innate immune processes involved in SARS-CoV-2 recognition and resultant inflammation

Using interdisciplinary approach to beat cancer

Older people at highest risk of death are least likely to receive effective COVID-19 treatment

Gene therapy helps heart muscle cells electrically activate in live mice

Scientists elucidate the structure of central cellular inflammatory switch

Drug used to treat skin and lung cancers slows the progression of ovarian cancer sub-type

New cloud-based data resource helps researchers to identify subtypes of ALS

Evaluating effects of D614G and P681R/H mutations on SARS-CoV-2 VOCs

Roswell Park scientists identify a potential new treatment target for pancreatic cancer

Scientists identify genome regions linked to migraine risk

Genome study reveals unexpected heterogeneity of human ribosomal RNA genes

Study offers unprecedented insight into the mechanism of action of topo VI enzyme

UK's world-leading human challenge study provides new insights into mild SARS-CoV-2 infections

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News